Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Due to numerous mutations in the spike protein, the SARS-CoV-2 variant of concern
Omicron (B.1.1.529) raises serious concerns since it may significantly limit the antibody-mediated …
Omicron (B.1.1.529) raises serious concerns since it may significantly limit the antibody-mediated …
[HTML][HTML] Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA. 1 and BA. 2 by convalescent and vaccine serum and monoclonal antibodies
Background In recent months, Omicron variants of SARS-CoV-2 have become dominant in
many regions of the world, and case numbers with Omicron subvariants BA.1 and BA.2 …
many regions of the world, and case numbers with Omicron subvariants BA.1 and BA.2 …
The ins (ide) and outs (ide) of dolichyl phosphate biosynthesis and recycling in the endoplasmic reticulum
B Schenk, F Fernandez, CJ Waechter - Glycobiology, 2001 - academic.oup.com
The precursor oligosaccharide donor for protein N-glycosylation in eukaryotes, Glc 3 Man 9
GlcNAc 2 -PP-dolichol, is synthesized in two stages on both leaflets of the rough …
GlcNAc 2 -PP-dolichol, is synthesized in two stages on both leaflets of the rough …
A Review of the Implementation of the Embryonic Stem Cell Test (EST) The report and recommendations of an ECVAM/ReProTect Workshop
…, U Reuter, V Rogiers, B Schenk… - Alternatives to …, 2009 - journals.sagepub.com
The new European chemicals policy for the Registration, Evaluation, Authorisation and
Restriction of Chemicals (the REACH system), requires the routine toxicological testing of …
Restriction of Chemicals (the REACH system), requires the routine toxicological testing of …
[HTML][HTML] MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If
B Schenk, T Imbach, CG Frank… - The Journal of …, 2001 - Am Soc Clin Investig
Deficiencies in the pathway of N-glycan biosynthesis lead to severe multisystem diseases,
known as congenital disorders of glycosylation (CDG). The clinical appearance of CDG is …
known as congenital disorders of glycosylation (CDG). The clinical appearance of CDG is …
Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death
L Probst, J Dächert, B Schenk, S Fulda - Biochemical pharmacology, 2017 - Elsevier
Ferroptosis has recently been identified as a mode of programmed cell death. However,
little is yet known about the signaling mechanism. Here, we report that lipoxygenases (LOX) …
little is yet known about the signaling mechanism. Here, we report that lipoxygenases (LOX) …
[HTML][HTML] Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie
T Imbach, B Schenk, E Schollen… - The Journal of …, 2000 - Am Soc Clin Investig
Congenital disorders of glycosylation (CDG), formerly known as carbohydrate-deficient
glycoprotein syndromes, lead to diseases with variable clinical pictures. We report the …
glycoprotein syndromes, lead to diseases with variable clinical pictures. We report the …
The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants
B Schenk, M Weimer, S Bremer, B van der Burg… - Reproductive …, 2010 - Elsevier
ReProTect is a project within the 6th European Framework Program which has developed
alternative methods aimed to reduce or replace animal experimentation in the field of …
alternative methods aimed to reduce or replace animal experimentation in the field of …
Smac mimetic bypasses apoptosis resistance in FADD-or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosis
B Laukens, C Jennewein, B Schenk… - Neoplasia, 2011 - Elsevier
Searching for new strategies to bypass apoptosis resistance, we investigated the potential
of the Smac mimetic BV6 in Jurkat leukemia cells deficient in key molecules of the death …
of the Smac mimetic BV6 in Jurkat leukemia cells deficient in key molecules of the death …
Follow up of cochlear implanted handicapped children
…, B Egelierler, P Franz, B Schenk… - International journal of …, 2000 - Elsevier
Objective: To document progress and benefit of multi-handicapped children using cochlear
implants. Design: The evaluation of auditory responses to speech (EARS) test battery was …
implants. Design: The evaluation of auditory responses to speech (EARS) test battery was …